en
Scientific article
Open access
English

Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone

Published inAnnals of oncology, vol. 8, no. 7, p. 681-684
Publication date1997
Abstract

Alteration of radiation therapy (RT) fractionation and the combination of chemotherapy (CT) with RT represent two predominant fields of current research in the treatment of head and neck carcinomas. To assess the potential integration of these two fields, a retrospective comparison of toxicity and treatment outcome was carried out in stage III-IV patients treated with a concomitant boost RT schedule with or without CT.

Keywords
  • Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use
  • Carcinoma/drug therapy/pathology/radiotherapy
  • Cisplatin/administration & dosage/adverse effects
  • Combined Modality Therapy
  • Female
  • Fluorouracil/administration & dosage/adverse effects
  • Head and Neck Neoplasms/drug therapy/pathology/radiotherapy
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Retrospective Studies
  • Treatment Outcome
Citation (ISO format)
ALLAL, Abdelkarim Said et al. Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone. In: Annals of oncology, 1997, vol. 8, n° 7, p. 681–684. doi: 10.1023/A:1008260720076
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0923-7534
501views
309downloads

Technical informations

Creation10/28/2013 9:31:00 PM
First validation10/28/2013 9:31:00 PM
Update time03/14/2023 8:50:44 PM
Status update03/14/2023 8:50:44 PM
Last indexation01/16/2024 1:54:32 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack